Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation

References

• Supuran CT. Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery. Expert Opin Drug Discov 2020;15:671–86.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases an overview. Curr Pharm Des 2008;14:603–14.
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 2000;10:575–600.
   Web of Science ®Google Scholar
• Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorganic Med Chem 2007;15:4336–50.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Supuran CT. Chapter 1 – carbonic anhydrases: an overview. In: Supuran C.T., Nocentini A.B.T.-C.A. eds. Carbonic anhydrases. Washington, DC: Academic Press; 2019:3–16.
   Google Scholar
• Nocentini A, Donald WA, Supuran CT, Chapter 8 – human carbonic anhydrases: tissue distribution, physiological role, and druggability, In: Supuran C.T., Nocentini A.B.T.-C.A. eds., Carbonic anhydrases. Washington, DC: Academic Press; 2019: 151–185.
   Google Scholar
• Provensi G, Carta F, Nocentini A, et al. A new kid on the block? Carbonic anhydrases as possible new targets in Alzheimer’s disease. Int J Mol Sci 2019;20:4724.
   PubMed Web of Science ®Google Scholar
• Gul HI, Yamali C, Sakagami H, et al. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Bioorg Chem 2018;77:411–9.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase activators. Future Med Chem 2018;10:561–73.
   PubMed Web of Science ®Google Scholar
• Solesio ME, Peixoto PM, Debure L, et al. Carbonic anhydrase inhibition selectively prevents amyloid β neurovascular mitochondrial toxicity. Aging Cell 2018;17:e12787.
   PubMed Web of Science ®Google Scholar
• Swietach P, Wigfield S, Cobden P, et al. Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths. J Biol Chem 2008;283:20473–83.
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target. Biochim Biophys Acta 2010;1804:404–9.
   PubMed Web of Science ®Google Scholar
• Ameis HM, Drenckhan A, Freytag M, et al. Carbonic anhydrase IX correlates with survival and is a potential therapeutic target for neuroblastoma. J Enzyme Inhib Med Chem 2015;0:1–6.
   Google Scholar
• Pastorekova S, Ratcliffe PJ, Pastorek J. Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 2008;101:8–15.
   PubMed Web of Science ®Google Scholar
• Thiry A, Dogné JM, Masereel B, Supuran CT. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol Sci 2006;27:566–73.
   PubMed Web of Science ®Google Scholar
• Lounnas N, Rosilio C, Nebout M, et al. Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas. Cancer Lett 2013;333:76–88.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov 2017;12:61–88.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Supuran CT. Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 2019;14:1175–97.
   PubMed Web of Science ®Google Scholar
• Berrino E, Supuran CT. Novel approaches for designing drugs that interfere with pH regulation. Expert Opin Drug Discov 2019;14:231–48.
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759–72.
   PubMed Web of Science ®Google Scholar
• Güzel-Akdemir Ö, Akdemir A, Karalı N, Supuran CT. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII. Org Biomol Chem 2015;13:6493–9.
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Monti SM, Hilvo M, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins Struct Funct Bioinforma 2009;74:164–75.
   PubMed Web of Science ®Google Scholar
• Angeli A, Pinteala M, Maier SS, et al. Evaluation of thio-and seleno-acetamides bearing benzenesulfonamide as inhibitor of carbonic anhydrases from different pathogenic bacteria. Int J Mol Sci 2020;21:1–8.
   Web of Science ®Google Scholar
• Angeli A, Peat TS, Selleri S, et al. X-ray crystallography of Epacadostat in adduct with Carbonic Anhydrase IX. Bioorg Chem 2020;97:103669.
   PubMed Web of Science ®Google Scholar
• Carradori S, Guglielmi P, Chapter 12, Mechanisms of action of carbonic anhydrase inhibitors: compounds that bind “out of the binding site” and compounds with an unknown mechanism of action. In: Supuran C.T., Nocentini A.B.T.-C.A. eds., Carbonic Anhydrases. Washington, DC: Academic Press; 2019: 257–268.
   Google Scholar
• Supuran CT. How many carbonic anhydrase inhibition mechanisms exist? J Enzyme Inhib Med Chem 2016;31:345–60.
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Carta F, Supuran CT. Secondary and tertiary sulfonamides: a patent review (2008–2012). Expert Opin Ther Pat 2013;23:203–13.
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421–68.
   PubMed Web of Science ®Google Scholar
• Köhler K, Hillebrecht A, Schulze Wischeler J, et al. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Angew Chem Int Ed Engl 2007;46:7697–9.
   PubMed Web of Science ®Google Scholar
• Coviello V, Marchi B, Sartini S, et al. 1,2-benzisothiazole derivatives bearing 4-, 5-, or 6-alkyl/arylcarboxamide moieties inhibit carbonic anhydrase isoform IX (CAIX) and cell proliferation under hypoxic conditions. J Med Chem 2016;59:6547–52.
   PubMed Web of Science ®Google Scholar
• Zubriene A, Čapkauskaite E, Gylyte J, et al. Benzenesulfonamides with benzimidazole moieties as inhibitors of carbonic anhydrases I, II, VII, XII and XIII. J Enzyme Inhib Med Chem 2014;29:124–31.
   PubMed Web of Science ®Google Scholar
• Ivanova J, Leitans J, Tanc M, et al. X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors. Chem Commun 2015;51:7108–11.
   PubMed Web of Science ®Google Scholar
• Alterio V, Tanc M, Ivanova J, et al. X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor. Org Biomol Chem 2015;13:4064–9.
   PubMed Web of Science ®Google Scholar
• Ivanova J, Carta F, Vullo D, et al. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII. Bioorganic Med Chem 2017;25:3583–9.
   PubMed Web of Science ®Google Scholar
• Carradori S, Secci D, De Monte C, et al. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms. Bioorg Med Chem 2016;24:1095–105.
   PubMed Web of Science ®Google Scholar
• D’Ascenzio M, Guglielmi P, Carradori S, et al. Open saccharin-based secondary sulfonamides as potent and selective inhibitors of cancer-related carbonic anhydrase IX and XII isoforms. J Enzyme Inhib Med Chem 2017;32:51–9.
   PubMed Web of Science ®Google Scholar
• D’Ascenzio M, Carradori S, De Monte C, et al. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII. Bioorg Med Chem 2014;22:1821–31.
   PubMed Web of Science ®Google Scholar
• Uda NR, Seibert V, Stenner-Liewen F, et al. Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity. J Enzyme Inhib Med Chem 2015;30:955–60.
   PubMed Web of Science ®Google Scholar
• Rotondi G, Guglielmi P, Carradori S, et al. Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold. J Enzyme Inhib Med Chem 2019;34:1400–13.
   PubMed Web of Science ®Google Scholar
• D’Ascenzio M, Secci D, Carradori S, et al. 1,3-dipolar cycloaddition, HPLC enantioseparation, and docking studies of saccharin/isoxazole and saccharin/isoxazoline derivatives as selective carbonic anhydrase IX and XII inhibitors. J Med Chem 2020;63:2470–88.
   PubMed Web of Science ®Google Scholar
• El-Gazzar MG, Nafie NH, Nocentini A, et al. Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates. J Enzyme Inhib Med Chem 2018;33:1565–74.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Ferraroni M, Carta F, et al. Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations. J Med Chem 2016;59:10692–704.
   PubMed Web of Science ®Google Scholar
• Kumar R, Vats L, Bua S, et al. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors. Eur J Med Chem 2018;155:545–51.
   PubMed Web of Science ®Google Scholar
• Vats L, Sharma V, Angeli A, et al. Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors. Eur J Med Chem 2018;150:678–86.
   PubMed Web of Science ®Google Scholar
• Murray AB, Lomelino CL, Supuran CT, McKenna R. “Seriously Sweet”: acesulfame K exhibits selective inhibition using alternative binding modes in carbonic anhydrase isoforms. J Med Chem 2018;61:1176–81.
   PubMed Web of Science ®Google Scholar
• De Monte C, Carradori S, Secci D, et al. Cyclic tertiary sulfamates: selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives. Eur J Med Chem 2014;84:240–6.
   PubMed Web of Science ®Google Scholar
• Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971;246:2561–73.
   PubMed Web of Science ®Google Scholar
• Bruno E, Buemi MR, Di Fiore A, et al. Probing molecular interactions between human carbonic anhydrases (hCAs) and a novel class of benzenesulfonamides. J Med Chem 2017;60:4316–26.
   PubMed Web of Science ®Google Scholar
• Angeli A, Vaiano F, Mari F, et al. Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII. J Enzyme Inhib Med Chem 2017;32:1253–9.
   PubMed Web of Science ®Google Scholar
• Angeli A, Tanini D, Capperucci A, et al. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism. Bioorg Chem 2018;81:642–8.
   PubMed Web of Science ®Google Scholar
• Mahon BP, Bhatt A, Socorro L, et al. The structure of carbonic anhydrase IX is adapted for low-pH catalysis. Biochemistry 2016;55:4642–53.
   PubMed Web of Science ®Google Scholar
• Whittington DA, Waheed A, Ulmasov B, et al. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells. Proc Natl Acad Sci USA 2001;98:9545–50.
   PubMed Web of Science ®Google Scholar
• Schrödinger Suite Release 2019-1, Schrödinger, LLC, New York, NY, 2019:(a) Prime, v.5.5; Maestro v.11.9;(b) Epik, v.4.7; (c) Impact, v.8.2; (d) Macromodel v.12.3. (e) Glide, v.8.2.
   Google Scholar
• Chen FMF, Benoiton NL. The preparation and reactions of mixed anhydrides of N -alkoxycarbonylamino acids. Can J Chem 1987;65:619–25.
   Web of Science ®Google Scholar
• Shao C, Wang X, Zhang Q, et al. Acid-base jointly promoted copper(I)-catalyzed azide-alkyne cycloaddition. J Org Chem 2011;76:6832–6.
   PubMed Web of Science ®Google Scholar
• Ghirga F, Quaglio D, Ghirga P, et al. Occurrence of enantioselectivity in nature: The case of (S)-norcoclaurine. Chirality 2016;28:169–80.
   Google Scholar